Basics |
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$148.96B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.36 | 0.99%
|
Avg Daily Range (30 D): |
$3.97 | 1.35%
|
Avg Daily Range (90 D): |
$3.46 | 1.19%
|
Institutional Daily Volume |
Avg Daily Volume: |
4.86M |
Avg Daily Volume (30 D): |
2.3M |
Avg Daily Volume (90 D): |
2.38M |
Trade Size |
Avg Trade Size (Sh.): |
135 |
Avg Trade Size (Sh.) (30 D): |
40 |
Avg Trade Size (Sh.) (90 D): |
43 |
Institutional Trades |
Total Inst.Trades: |
112,634 |
Avg Inst. Trade: |
$6.13M |
Avg Inst. Trade (30 D): |
$39.69M |
Avg Inst. Trade (90 D): |
$33.89M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
20 |
Market Closing Trades |
Avg Closing Trade: |
$63.74M |
Avg Closing Trade (30 D): |
$201.77M |
Avg Closing Trade (90 D): |
$181.95M |
Avg Closing Volume: |
385.93K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$7.89
|
$5.27
|
$1.39
|
Diluted EPS
|
$7.82
|
$5.22
|
$1.38
|
Revenue
|
$ 32.53B
|
$ 8.5B
|
$ 8.39B
|
Gross Profit
|
$ 19.68B
|
$ 5.19B
|
$ 5.15B
|
Net Income / Loss
|
$ 4.23B
|
$ 2.83B
|
$ 746M
|
Operating Income / Loss
|
$ 6.22B
|
$ 2.05B
|
$ 1.91B
|
Cost of Revenue
|
$ 12.86B
|
$ 3.31B
|
$ 3.24B
|
Net Cash Flow
|
$ -25730M
|
$ -290M
|
$ -407M
|
PE Ratio
|
35.97
|
|
|
|